Fiera Capital (Canada)’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
Fiera Capital (Canada)'s SWTX Position: Q2 2025 in Review
Fiera Capital (Canada) sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 1,224,210 shares — an estimated $54M sold.
Fiera Capital (Canada) first reported a position in SWTX in Q3 2021 and held it in 15 quarters. The position peaked at $54M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Fiera Capital (Canada) reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Fiera Capital (Canada) sold 1,224,210 SpringWorks Therapeutics shares in Q2 2025, an estimated $54M.
- Fiera Capital (Canada) first reported a position in SpringWorks Therapeutics in Q3 2021 and held it in 15 quarters.
- Fiera Capital (Canada)'s SpringWorks Therapeutics position peaked at $54M in Q1 2025.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Fiera Capital (Canada)'s 13F filing for Q2 2025, filed 8 Aug 2025.